Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization

被引:81
作者
Rennert, PD
Browning, JL
Hochman, PS
机构
[1] Dept. of Immunology/Inflammation, Biogen Inc., 14 Cambridge Center, Cambridge
关键词
addressin; germinal center; lymph node; lymphotoxin; MAdCAM-1; primary follicle; spleen; tumor necrosis factor;
D O I
10.1093/intimm/9.11.1627
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lymphotoxin (LT) provides a critical signal for the genesis of lymph nodes (LN) in mice, Here we show that mice treated in utero with LT beta-R-IQ, which binds to the membrane LT alpha 1 beta 2 heterotrimer, lacked most LN, yet retained a set of mucosal surface draining LN, Since mice genetically deficient in LT alpha lack all LN, including the mucosal set, we hypothesize that a novel LT alpha-dependent pathway controls their genesis. This novel set of mucosal LN cannot be discriminated on the basis of addressin expression, The discovery of LN in mice treated with LT beta-R-Ig fusion protein in utero allowed us to compare the roles of membrane LT alpha beta or soluble LT alpha/tumor necrosis factor (TNF) in the development of cellular organization in LN and spleen. Our results indicate that both membrane LT alpha beta and soluble LT alpha/TNF mediate T-B cell segregation and the organization of a cell follicles in spleen and LN. Interestingly, while antagonism of membrane LT alpha beta or soluble LT alpha/TNF prevented germinal center (GC) formation in spleen, antagonism of soluble LT alpha/TNF had no effect on LN formation, The data suggest that multiple LT/TNF ligands control a cell follicle organization in the spleen and LN of adult mice, and that the requirements for LT/TNF ligands in GC formation are distinct in the different lymphoid organs.
引用
收藏
页码:1627 / 1639
页数:13
相关论文
共 35 条
[1]   Differential requirements for alpha 4 integrins during fetal and adult hematopoiesis [J].
Arroyo, AG ;
Yang, JT ;
Rayburn, H ;
Hynes, RO .
CELL, 1996, 85 (07) :997-1008
[2]  
BANKS TA, 1995, J IMMUNOL, V155, P1685
[3]   EXPRESSION OF RELB IS REQUIRED FOR THE DEVELOPMENT OF THYMIC MEDULLA AND DENDRITIC CELLS [J].
BURKLY, L ;
HESSION, C ;
OGATA, L ;
REILLY, C ;
MARCONI, LA ;
OLSON, D ;
TIZARD, R ;
CATE, R ;
LO, D .
NATURE, 1995, 373 (6514) :531-536
[4]   A Lymphotoxin-β-Specific Receptor [J].
Crowe, Paul D. ;
VanArsdale, Todd L. ;
Walter, Barbara N. ;
Ware, Carl F. ;
Hession, Catherine ;
Ehrenfels, Barbara ;
Browning, Jeffrey L. ;
Din, Wenie S. ;
Goodwin, Raymond G. ;
Smith, Craig A. .
JOURNAL OF IMMUNOLOGY, 2014, 192 (05) :2015-2018
[5]  
CUSTER RP, 1985, AM J PATHOL, V120, P464
[6]   Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in Lymphotoxin [J].
De Togni, Pietro ;
Goellner, Josphe ;
Ruddle, Nancy H. ;
Streeter, Philip R. ;
Fick, Andrea ;
Mariathasan, Sanjeev ;
Smith, Stacy C. ;
Carison, Rebecca ;
Shonnick, Laurie P. ;
strauss-Schoenberger, Jena ;
Russell, John H. ;
Karr, Robert ;
Chaplin, David D. .
JOURNAL OF IMMUNOLOGY, 2014, 192 (05) :2010-2014
[7]   DECREASED SENSITIVITY TO TUMOR-NECROSIS-FACTOR BUT NORMAL T-CELL DEVELOPMENT IN TNF RECEPTOR-2-DEFICIENT MICE [J].
ERICKSON, SL ;
DESAUVAGE, FJ ;
KIKLY, K ;
CARVERMOORE, K ;
PITTSMEEK, S ;
GILLETT, N ;
SHEEHAN, KCF ;
SCHREIBER, RD ;
GOEDDEL, DV ;
MOORE, MW .
NATURE, 1994, 372 (6506) :560-563
[8]   Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein [J].
Ettinger, R ;
Browning, JL ;
Michie, SA ;
vanEwijk, W ;
McDevitt, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (23) :13102-13107
[9]   A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen [J].
Forster, R ;
Mattis, AE ;
Kremmer, E ;
Wolf, E ;
Brem, G ;
Lipp, M .
CELL, 1996, 87 (06) :1037-1047
[10]   Immune regulation by CD40 and its ligand GP39 [J].
Foy, TM ;
Aruffo, A ;
Bajorath, J ;
Buhlmann, JE ;
Noelle, RJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :591-617